← Back to Clinical Trials
Recruiting NCT06307977

NCT06307977 Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06307977
Status Recruiting
Phase
Sponsor Hunter College of City University of New York
Condition Substance Use
Study Type INTERVENTIONAL
Enrollment 360 participants
Start Date 2024-05-25
Primary Completion 2028-01

Trial Parameters

Condition Substance Use
Sponsor Hunter College of City University of New York
Study Type INTERVENTIONAL
Phase N/A
Enrollment 360
Sex MALE
Min Age 18 Years
Max Age 55 Years
Start Date 2024-05-25
Completion 2028-01
Interventions
Couples Health Project

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI or standard couples HIV testing and counseling (CHTC).

Eligibility Criteria

Inclusion Criteria: * Have a main partner who is another cisgender male and have been in a relationship for 3 month or longer * Index participant must be between 18 and 55; Main partner can be any age 18 and older * One participant must be HIV negative (as confirmed by rapid test) * One participant must have used at least 1 drug in the past 30 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB, amyl nitrite) * Index participant must have engaged in TRB in the past 30 days- Defined as CAS with a casual partner, or a serodiscordant or non-monogamous main partner * Live in the United States * Speak and read English Exclusion Criteria * Any signs of serious mental illness or cognitive deficit * Current suicidal/homicidal ideations * History of IPV with their main partner and safety concerns in the current relationship.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology